Dr. Jonathan W. Goldman
Claim this profileUCLA / Jonsson Comprehensive Cancer Center
Expert in Lung Cancer
Studies Non-Small Cell Lung Cancer
14 reported clinical trials
20 drugs studied
Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
RET positive
2Non-Small Cell Lung Cancer
Stage III
Stage IV
RET positive
Affiliated Hospitals
Clinical Trials Jonathan W. Goldman is currently running
UCT-03-008
for Advanced Solid Cancers
This trial is testing a new drug called UCT-03-008 in patients with advanced cancers that have spread. The goal is to see if the drug is safe, how it behaves in the body, and if it can help fight the cancer.
Recruiting1 award Phase 1
Tarlatamab
for Neuroendocrine Tumors
This study is being done to learn more about the drug tarlatamab in people with your condition. The purpose of this study is to see the efficacy (how well something works) of study treatment (tarlatamab) and whether it causes any side effects. Tarlatamab is being developed as an anti-cancer drug for tumors and is FDA-approved for extensive-stage small cell lung cancer. Tarlatamab is investigational for the purpose of this study.
Recruiting1 award Phase 23 criteria
More about Jonathan W. Goldman
Clinical Trial Related7 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Jonathan W. Goldman has experience with
- Temozolomide
- Placebo
- Osimertinib
- Pembrolizumab
- Talazoparib
- Niraparib
Breakdown of trials Jonathan W. Goldman has run
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Solid Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jonathan W. Goldman specialize in?
Jonathan W. Goldman focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Jonathan W. Goldman currently recruiting for clinical trials?
Yes, Jonathan W. Goldman is currently recruiting for 3 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Jonathan W. Goldman has studied deeply?
Yes, Jonathan W. Goldman has studied treatments such as Temozolomide, Placebo, Osimertinib.
What is the best way to schedule an appointment with Jonathan W. Goldman?
Apply for one of the trials that Jonathan W. Goldman is conducting.
What is the office address of Jonathan W. Goldman?
The office of Jonathan W. Goldman is located at: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California 90095 United States. This is the address for their practice at the UCLA / Jonsson Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.